Plc Astrazeneca serves as Executive at PhaseBio Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Plc Astrazeneca has executed 6 insider transactions totaling $14.8M, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 7, 2019 involved exercising options for 14,225,324 shares valued at $0.
Plc Astrazeneca currently holds 14,225,334 shares of PhaseBio Pharmaceuticals Inc (PHAS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Plc Astrazeneca has been a net buyer of PHAS stock. They have purchased $14.8M and sold $0 worth of shares.
Plc Astrazeneca's most recent insider trade was on Oct 7, 2019, when they sold 14,225,324 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $19.00 |
| Discretionary |
| Oct 22, 2018 | PHAS | $3.0M | Purchase | 600,000 | $5.00 | Discretionary |
| Oct 22, 2018 | PHAS | $0 | Conversion | 2,404,554 | $N/A | Discretionary |
| Sep 28, 2018 | ETTX | $3.7M | Purchase | 246,666 | $15.00 | Discretionary |
| Sep 28, 2018 | ETTX | $0 | Conversion | 1,918,185 | $N/A | Discretionary |